David Deshan
Obstetrics & Gynecology · Midland, TXNPI 1891706040
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 34.8% of the total. Reporting peaked in 2022 at $618 and has fallen 90.9% since, to $56 in 2023.
Across 80 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$524
- Amgen$197
- Astellas Pharma US Inc$170
- Axonics, Inc.$93
- Hologic Sales And Service, LLC$73
- Daiichi Sankyo Inc.$58
- plus $389 from 15 others
What the payments were for
- Food & beverage$1,41994%
- Education$856%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $524 |
| Amgen | 10 | $197 |
| Astellas Pharma US Inc | 7 | $170 |
| Axonics, Inc. | 5 | $93 |
| Hologic Sales And Service, LLC | 1 | $73 |
| Daiichi Sankyo Inc. | 3 | $58 |
| Arbor Pharmaceuticals, Inc. | 1 | $53 |
| Coopersurgical, Inc. | 1 | $46 |
| Lupin Inc. | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Bayer | 2 | $35 |
| Therapeuticsmd, Inc. | 2 | $32 |
| Exeltis, USA Inc. | 2 | $31 |
| Ortho-clinical Diagnostics, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Organon | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
| Avion Pharmaceuticals | 1 | $12 |
| Mission Pharmacal Company | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
How this compares
$1,504 in reported general payments places this provider in the 60th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $118 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Midland
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.